Marcie A. Goldstein

Davis Polk advised the joint book-running managers in connection with a $138 million SEC-registered offering of 4,450,500 shares of common stock of Loxo Oncology, Inc. The common stock is…

Davis Polk advised the joint book-running managers in connection with the approximately $237 million primary offering of 10,000,000 shares of common stock of Summit Materials, Inc. The…

Davis Polk advised the joint book-running managers in connection with the $100.9 million public offering of common stock of Achaogen, Inc. The common stock is listed onthe NASDAQ Global…

Davis Polk advised the sole book-running manager in connection with the $126.5 million public offering of common stock of Xencor, Inc. The common stock is listed on the NASDAQ Global Market…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $106.3 million follow-on offering of 3,864,000 shares of common stock of…

Davis Polk advised the joint book-running managers and representatives of the underwriters in the $200 million public offering by BeiGene, Ltd. of 6,250,000 American Depositary Shares, of…

Davis Polk advised the joint book-running managers in connection with an SEC-registered reopening of €200 million aggregate principal amount of 1.850% senior notes due 2023 by Bunge Finance…

Davis Polk advised the sole underwriter in connection with the approximately $367 million secondary offering of 16,614,949 shares of common stock of Summit Materials, Inc. by certain…

Davis Polk advised the underwriter in connection with the $1.3 billion secondary offering of 55,000,000 shares of common stock of Hilton Worldwide Holdings Inc. by certain selling…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Century Communities, Inc. of its shares of common stock for up to an aggregate amount of …